Sleep Quality, Metabolic Link May Surprise You

Poor sleep quality and short sleep duration are associated with adiposity, obesity, and other cardiometabolic conditions such as type 2 diabetes, according to a new study.

 

To reach this conclusion, the researchers analyzed data on 1986 participants from the PREDIMED-Plus trial. All the participants were aged 65 years or older, were overweight or obese, and had metabolic syndrome.


IF YOU LIKE THIS, READ MORE...

New Screening Tool Helps Identify Sleep Apnea in Patients With Epilepsy

Parkinson Disease and Sleep Disorders: What’s the Connection?


The associations of accelerometry-derived sleep duration and sleep variability with body mass index, waist circumference, and body composition were assessed. Prevalence ratios for obesity and type 2 diabetes were also determined.

 

The participants were categorized and examined as either “bad sleepers,” defined as age-specific non-recommended sleep duration plus sleep variability above the median, or “good sleepers,” defined as age-specific recommended sleep duration plus sleep variability below the median.

 

Results showed that a 1-hour per night increment in sleep duration was inversely associated with body mass index, waist circumference, obesity, type 2 diabetes, and other absorptiometry-derived adiposity-related measurements.

 

The researchers found that among those categorized as bad sleepers, there was a positive association with obesity compared with good sleepers.

 

“This study revealed cross-sectional associations of sleep duration with adiposity parameters and obesity,” the researchers concluded. “Sleep duration and sleep variability were associated with type 2 diabetes. Considering simultaneously sleep duration and sleep variability could have additional value, particularly for type 2 diabetes, as they may act synergistically.”

 

—Colleen Murphy

 

Reference:

Rosique-Esteban N, Papandreou C, Romaguera D, et al. Cross-sectional associations of objectively-measured sleep characteristics with obesity and type 2 diabetes in the PREDIMED-Plus trial. Sleep. 2018;41(12):zsy190. https://doi.org/10.1093/sleep/zsy190.